Metallomics in drug development: Characterization of a liposomal cisplatin drug formulation in human plasma by CE-ICP-MS

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 6, 2013, Pages 1845-1854

  Nguyen, Tam T T N ^a   Østergaard, Jesper ^a   Stürup, Stefan ^a   Gammelgaard, Bente ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CE ICP MS; Cisplatin; Drug development; Human plasma; PEGylated liposomes

Indexed keywords

CAPILLARY ELECTROPHORESIS; DRUG PRODUCTS; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; LIPOSOMES; MASS SPECTROMETERS; PLASMA (HUMAN); PLASMA STABILITY; PLATINUM; PROTEINS; SODIUM DODECYL SULFATE; SULFUR COMPOUNDS;

CE-ICP-MS; CIS-PLATIN; DRUG DEVELOPMENT; HUMAN PLASMAS; PEGYLATED LIPOSOMES;

DRUG DELIVERY;

EID: 84873703675     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6355-2     Document Type: Article

References (43)

1. Haraguchi H (2004) Metallomics as integrated biometal science. J Anal At Spectrom 19:5-14
2. Szpunar J (2005) Advances in analytical methodology for bioinorganic speciation analysis: metallomics, metalloproteomics and heteroatom-tagged proteomics and metabolomics. Analyst 130:442-465
3. Meermann B, Sperling M (2012) Hyphenated techniques as tools for speciation analysis of metal-based pharmaceuticals: developments and applications. Anal Bioanal Chem 403:1501-1522
4. Wang M, Feng W, Lu W, Li B, Wang B, Zhu M, Wang Y, Yuan H, Zhao Y, Chai Z (2007) Quantitative analysis of proteins via sulfur determination by HPLC coupled to isotope dilution ICPMS with a hexapole collision cell. Anal Chem 79:9128-9134
5. Siethoff C, Feldmann I, Jakubowski N, Linscheid M (1999) Quantitative determination of DNA adducts using liquid chromatography/electrospray ionization mass spectrometry and liquid chromatography/high-resolution inductively coupled plasma mass spectrometry. J Mass Spectrom 34:421-426
6. Profrock D, Leonhard P, Prange A (2003) Determination of phosphorus in phosphorylated deoxyribonucleotides using capillary electrophoresis and high performance liquid chromatography hyphenated to inductively coupled plasma mass spectrometry with an octopole reaction cell. J Anal At Spectrom 18:708-713
7. Bytzek AK, Hartinger CG (2012) Capillary electrophoretic methods in the development of metal-based therapeutics and diagnostics: new methodology and applications. Electrophoresis 33:622-634
8. Albert A, Brauckmann C, Blaske F, Sperling M, Engelhard C, Karst U (2012) Speciation analysis of the antirheumatic agent Auranofin and its thiol adducts by LC/ESI-MS and LC/ICP-MS. J Anal At Spectrom 27:975-981
9. Groessl M, Hartinger CG, Dyson PJ, Keppler BK (2008) CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP. J Inorg Biochem 102:1060-1065
10. Jahn S, Lohmann W, Bomke S, Baumann A, Karst U (2012) A ferrocene-based reagent for the conjugation and quantification of reactive metabolites. Anal Bioanal Chem 402:461-471
11. Gammelgaard B, Packert Jensen B (2007) Application of inductively coupled plasma mass spectrometry in drug metabolism studies. J Anal At Spectrom 22:235-249
12. Koellensperger G, Groeger M, Zinkl D, Petzelbauer P, Hann S (2009) Quantification of elemental labeled peptides in cellular uptake studies. J Anal At Spectrom 24:97-102
13. Prange A, Profrock D (2008) Chemical labels and natural element tags for the quantitative analysis of bio-molecules. J Anal At Spectrom 23:432-459
14. Ranson M, Howell A, Cheeseman S, Margison J (1996) Liposomal drug delivery. Cancer Treat Rev 22:365-379
15. Wang AZ, Langer R, Farokhzad OC (2012) Nanoparticle delivery of cancer drugs. Annu Rev Med 63:185-198
16. Florea A-M, Büsselberg D (2011) Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers 3:1351-1371
17. Rajeswaran A, Trojan A, Burnand B, Giannelli M (2008) Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials. Lung Cancer 59:1-11
18. Maurer N, Fenske DB, Cullis PR (2001) Developments in liposomal drug delivery systems. Expert Opin Biol Ther 1:923-947
19. Andresen TL, Jensen SS, Jorgensen K (2005) Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 44:68-97
20. Metselaar JM, Mastrobattista E, Storm G (2002) Liposomes for intravenous drug targeting: design and applications. Mini Rev Med Chem 2:319-329
21. Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145-160
22. Falta T, Koellensperger G, Standler A, Buchberger W, Mader RM, Hann S (2009) Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP-SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection. J Anal At Spectrom 24:1336-1342
23. Groessl M, Terenghi M, Casini A, Elviri L, Lobinski R, Dyson PJ (2010) Reactivity of anticancer metallodrugs with serum proteins: new insights from size exclusion chromatography-ICP-MS and ESI-MS. J Anal At Spectrom 25:305-313
24. Speelmans G, Sips WH, Grisel RJ, Staffhorst RW, Fichtinger-Schepman AM, Reedijk J, deKruijff B (1996) The interaction of the anti-cancer drug cisplatin with phospholipids is specific for negatively charged phospholipids and takes place at low chloride ion concentration. Biochim Biophys Acta 1283:60-66
25. Hawkins MJ, Soon-Shiong P, Desai N (2008) Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliver Rev 60:876-885
26. Moller C, Tastesen HS, Gammelgaard B, Lambert IH, Sturup S (2010) Stability, accumulation and cytotoxicity of an albumin-cisplatin adduct. Metallomics 2:811-818
27. Hann S, Falta T, Boeck K, Sulyok M, Koellensperger G (2010) On-line fast column switching SEC × IC separation combined with ICP-MS detection for mapping metallodrug-biomolecule interaction. J Anal At Spectrom 25:861-866
28. Timerbaev AR, Aleksenko SS, Polec-Pawlak K, Ruzik R, Semenova O, Hartinger CG, Oszwaldowski S, Galanski M, Jarosz M, Keppler BK (2004) Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin. Electrophoresis 25:1988-1995
29. Szpunar J, Makarov A, Pieper T, Keppler BK, Lobinski R (1999) Investigation of metallodrug-protein interactions by size-exclusion chromatography coupled with inductively coupled plasma mass spectrometry (ICP-MS). Anal Chim Acta 387:135-144
30. Michalke B (2010) Platinum speciation used for elucidating activation of Pt-containing anti-cancer drugs. J Trace Elem Med Biol 24:69-77
31. Timerbaev AR, Pawlak K, Aleksenko SS, Foteeva LS, Matczuk M, Jarosz M (2012) Advances of CE-ICP-MS in speciation analysis related to metalloproteomics of anticancer drugs. Talanta. doi: 10.1016/j.talanta.2012.07.031
32. Nguyen TTTN, Sturup S, Ostergaard J, Franzen U, Gammelgaard B (2011) Simultaneous measurement of phosphorus and platinum by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry (SEC-ICPMS) using xenon as reactive collision gas for characterization of platinum drug liposomes. J Anal At Spectrom 26:1466-1473
33. Nguyen T, Ostergaard J, Sturup S, Gammelgaard B (2012) Investigation of a liposomal oxaliplatin drug formulation by capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry (CE-ICP-MS). Anal Bioanal Chem 402:2131-2139
34. Vikbjerg AF, Petersen SA [DK], Melander F [SE], Henriksen JR [DK], Joergensen K [DK] (2009) Liposomes for drug delivery and methods for preparation thereof. WO2009EP56297 20090525 [WO2009141450 (A2)]. Ref Type: Patent
35. Franzen U, Nguyen TTTN, Vermehren C, Gammelgaard B, Ostergaard J (2011) Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage. J Pharm Biomed 55:16-22
36. Hann S, Koellensperger G, Stefanka Z, Stingeder G, Furhacker M, Buchberger W, Mader RM (2003) Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine. J Anal At Spectrom 18:1391-1395
37. Østergaard J, Schou C, Larsen C, Heegaard NHH (2002) Effect of dextran as a run buffer additive in drug-protein binding studies using capillary electrophoresis frontal analysis. Anal Chem 75:207-214
38. Khan AM, Shah SS (2008) Determination of critical micelle concentration (cmc) of sodium dodecyl sulfate (SDS) and the effect of low concentration of pyrene on its cmc using ORIGIN software. J Chem Soc Pak 30:186-191
39. Michalke B, Schramel P (1997) Coupling of capillary electrophoresis with ICP-MS for speciation investigations. Fresenius J Anal Chem 357:594-599
40. Xu X, Khan MA, Burgess DJ (2012) A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes. Int J Pharm 426:211-218
41. Boyd BJ (2003) Characterisation of drug release from cubosomes using the pressure ultrafiltration method. Int J Pharm 260:239-247
42. Washington C (1989) Evaluation of non-sink dialysis methods for the measurement of drug release from colloids: effects of drug partition. Int J Pharm 56:71-74
43. de Jonge MJ, Slingerland M, Loos WJ, Wiemer EAC, Burger H, Mathijssen RHJ, Kroep JR, den Hollander MAG, van der Biessen D, Lam MH, Verweij J, Gelderblom H (2010) Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation. Eur J Cancer 46:3016-3021